David JD - Brickell Biotech G Officer

BBIDelisted Stock  USD 1.79  0.34  23.45%   

Insider

David JD is G Officer of Brickell Biotech
Age 61
Phone720 505 4755
Webhttps://www.brickellbio.com

Brickell Biotech Management Efficiency

The company has Return on Asset of (0.802) % which means that on every $100 spent on assets, it lost $0.802. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (1.5729) %, meaning that it generated no profit with money invested by stockholders. Brickell Biotech's management efficiency ratios could be used to measure how well Brickell Biotech manages its routine affairs as well as how well it operates its assets and liabilities.
Brickell Biotech has 69 K in debt with debt to equity (D/E) ratio of 0.0, which may show that the company is not taking advantage of profits from borrowing. Brickell Biotech has a current ratio of 4.27, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Brickell to invest in growth at high rates of return.

Similar Executives

Showing other executives

INSIDER Age

Mark LappeInhibrx
57
Eric NarimatsuBarfresh Food Group
N/A
Wong JDMind Medicine
54
Leonard LatchmanMind Medicine
N/A
Cheng LiI Mab
40
Veronique LecaultAbcellera Biologics
39
JD EsqAbcellera Biologics
54
Alexandra MScAbcellera Biologics
N/A
Robert BarrowMind Medicine
35
Saurabh MDCentessa Pharmaceuticals PLC
48
MD MAMind Medicine
44
Joshua MBACentessa Pharmaceuticals PLC
50
Richard MBAI Mab
56
David GraingerCentessa Pharmaceuticals PLC
55
Lisa RogerBarfresh Food Group
56
David CPAChimerix
46
Ivan ZhuI Mab
55
Karen AndersonCentessa Pharmaceuticals PLC
56
Scott MDMind Medicine
67
M CIPDAbcellera Biologics
N/A
MD MScCentessa Pharmaceuticals PLC
64
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company was founded in 2009 and is headquartered in Boulder, Colorado. Brickell Biotech operates under Biotechnology classification in the United States and is traded on NCM Exchange. It employs 16 people. Brickell Biotech (BBI) is traded on NASDAQ Exchange in USA and employs 16 people.

Management Performance

Brickell Biotech Leadership Team

Elected by the shareholders, the Brickell Biotech's board of directors comprises two types of representatives: Brickell Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Brickell. The board's role is to monitor Brickell Biotech's management team and ensure that shareholders' interests are well served. Brickell Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Brickell Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
Albert II, CFO Officer
Andrew Sklawer, President, CoFounder
Nancy Seretta, VP Operations
PM MBA, VP Operations
Gary Walker, Chief Officer
David JD, G Officer
Attorney Brown, CEO Director
RPh MBA, CoFounder Chairman
Sue Fattor, Head Resource
MBA MS, Chief Officer

Brickell Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Brickell Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Brickell Stock

If you are still planning to invest in Brickell Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Brickell Biotech's history and understand the potential risks before investing.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Transaction History
View history of all your transactions and understand their impact on performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account